The authors discuss the experience of another group with rapamycin as the principal immunosuppressive drug in HIV positive recipients of liver transplantation. We would suggest that control of HIV-RNA viremia in liver transplanted patients is still a matter of the choice of the best ART independently from the type of the antirejection treatment.

mTOR Immunosuppression in HIV-Positive Liver Transplant Recipients

VIALE, PIERLUIGI
2010

Abstract

The authors discuss the experience of another group with rapamycin as the principal immunosuppressive drug in HIV positive recipients of liver transplantation. We would suggest that control of HIV-RNA viremia in liver transplanted patients is still a matter of the choice of the best ART independently from the type of the antirejection treatment.
Baccarani U; Adani GL; Tavio M; Grossi P; Viale P.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/93219
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact